The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect

被引:19
|
作者
Shimabukuro-Vornhagen, Alexander [1 ,2 ]
Liebig, Tanja M. [1 ]
Koslowsky, Thomas [3 ]
Theurich, Sebastian [1 ,2 ]
von Bergwelt-Baildon, Michael S. [1 ,2 ]
机构
[1] Univ Hosp Cologne, Dept Internal Med 1, D-50924 Cologne, Germany
[2] Univ Hosp Cologne, Dept Internal Med 1, Stem Cell Transplantat Program, Cologne, Germany
[3] St Elizabeth Hosp, Dept Surg, Cologne, Germany
关键词
Prostaglandin E-2; IDO; Dendritic cell; Cancer vaccine; Tumor-induced immunosuppression; INDOLEAMINE 2,3-DIOXYGENASE; KEY FACTOR; MATURATION; PGE(2); CANCER; EXPRESSION; IDO; PROLIFERATION; MIGRATION; CHEMOKINE;
D O I
10.1016/j.cellimm.2013.01.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Prostaglandin E-2 has been shown to enhance the maturation, migration, and antigen-presenting capacity of DCs. It is therefore included in many maturation cocktails for the generation of monocyte-derived DCs. Paradoxically, PGE(2) is also an important tumor-derived immunosuppressive factor and has inhibitory effects on DC differentiation and function. To further investigate these seemingly contradictory results we studied whether the DC:T cell ratio has an impact on the outcome of the interaction between PGE(2)-treated DCs and T cells. Surprisingly, at high DC:T cell ratios T cell proliferation was inhibited while at low ratios PGE(2)-treated DCs displayed enhanced T cell-stimulatory properties. The inhibitory function of PGE(2)-treated DCs depended primarily on the PGE(2)-induced induction of indoleamine 2,3-dioxygenase competence. In summary, we show that PGE(2)-treated DCs can have either an immunogenic or tolerogenic function depending on the DC:T cell ratio. This finding could explain the conflicting results regarding the influence of PGE(2) on DC function. (c) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 50 条
  • [31] The whipworm (Trichuris suis) secretes prostaglandin E2 to suppress proinflammatory properties in human dendritic cells
    Laan, Lisa C.
    Williams, Andrew R.
    Stavenhagen, Kathrin
    Giera, Martin
    Kooij, Gijs
    Vlasakov, Iliyan
    Kalay, Hakan
    Kringel, Helene
    Nejsum, Peter
    Thamsborg, Stig M.
    Wuhrer, Manfred
    Dijkstra, Christine D.
    Cummings, Richard D.
    van Die, Irma
    [J]. FASEB JOURNAL, 2017, 31 (02): : 719 - 731
  • [32] Prostaglandin E2 suppresses the differentiation of retinoic acid-producing dendritic cells in mice and humans
    Stock, Angus
    Booth, Sarah
    Cerundolo, Vincenzo
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (04): : 761 - 773
  • [33] Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells
    Vassiliou, E
    Jing, H
    Ganea, D
    [J]. CELLULAR IMMUNOLOGY, 2003, 223 (02) : 120 - 132
  • [34] Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells
    Shiraishi, Hiroshi
    Yoshida, Hideyuki
    Saeki, Kazuko
    Miura, Yoshiki
    Watanabe, Satoko
    Ishizaki, Takuma
    Hashimoto, Masayuki
    Takaesu, Giichi
    Kobayashi, Takashi
    Yoshimura, Akihiko
    [J]. INTERNATIONAL IMMUNOLOGY, 2008, 20 (09) : 1219 - 1229
  • [35] Activated human dendritic cells express inducible cyclo-oxygenase and synthesize prostaglandin E2 but not prostaglandin D2
    Fogel-Petrovic, M
    Long, JA
    Knight, DA
    Thompson, PJ
    Upham, JW
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (01): : 47 - 54
  • [36] Inhibitory effect of Mao-Bushi-Saishin-to on prostaglandin E2 synthesis in C6 rat glioma cells
    Saito, SY
    Kamiyama, S
    Oda, M
    Nakahata, N
    Ohizumi, Y
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (07) : 1133 - 1135
  • [37] Prostaglandin E2 inhibits proliferation of bovine NK cells
    Tomasz Maślanka
    [J]. Pharmacological Reports, 2013, 65 (Suppl 1) : 65 - 65
  • [38] Induction of macrophagic prostaglandin E2 synthesis by glioma cells
    Nakano, Y
    Kuroda, E
    Kito, T
    Yokota, A
    Yamashita, U
    [J]. JOURNAL OF NEUROSURGERY, 2006, 104 (04) : 574 - 582
  • [39] Stimulation of angiogenesis by prostaglandin e2 in luteal endothelial cells
    Tamura, Kazuhiro
    Tachikawa, Eiichi
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S602 - S602
  • [40] PROSTAGLANDIN (PG)-E2 RECEPTORS ON PORCINE CHIEF CELLS
    SEWING, KF
    BEINBORN, M
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (07) : 909 - 909